1. Home
  2. BLCO vs GNTX Comparison

BLCO vs GNTX Comparison

Compare BLCO & GNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$15.03

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Gentex Corporation

GNTX

Gentex Corporation

HOLD

Current Price

$25.73

Market Cap

5.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLCO
GNTX
Founded
1853
1974
Country
Canada
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.0B
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
BLCO
GNTX
Price
$15.03
$25.73
Analyst Decision
Buy
Hold
Analyst Count
11
5
Target Price
$18.45
$26.60
AVG Volume (30 Days)
404.4K
2.1M
Earning Date
04-29-2026
04-24-2026
Dividend Yield
N/A
2.10%
EPS Growth
N/A
N/A
EPS
N/A
0.46
Revenue
$5,101,000,000.00
$2,534,268,965.00
Revenue This Year
$8.65
$6.89
Revenue Next Year
$5.59
$4.58
P/E Ratio
N/A
$56.61
Revenue Growth
6.47
9.55
52 Week Low
$11.44
$20.48
52 Week High
$18.92
$29.38

Technical Indicators

Market Signals
Indicator
BLCO
GNTX
Relative Strength Index (RSI) 40.00 68.39
Support Level $14.55 $25.60
Resistance Level $15.67 $29.06
Average True Range (ATR) 0.38 0.55
MACD -0.02 0.12
Stochastic Oscillator 25.91 74.24

Price Performance

Historical Comparison
BLCO
GNTX

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About GNTX Gentex Corporation

Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion, with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.

Share on Social Networks: